Corindus Vascular Robotics, Inc. (CVRS) Analysts See $-0.04 EPS

Analysts expect Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) to report $-0.04 EPS on March, 13.They anticipate $0.00 EPS change or 0.00 % from last quarter’s $-0.04 EPS. After having $-0.04 EPS previously, Corindus Vascular Robotics, Inc.’s analysts see 0.00 % EPS growth. The stock decreased 3.55% or $0.05 during the last trading session, reaching $1.36. About 370,298 shares traded. Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) has risen 50.50% since March 8, 2018 and is uptrending. It has outperformed by 46.13% the S&P500.

Corindus Vascular Robotics, Inc. designs, makes, and sells robotic-assisted precision vascular intervention systems for use in interventional vascular procedures. The company has market cap of $260.20 million. The firm offers CorPath system, a medical device with robotic-assisted precision for radial, coronary, and peripheral procedures. It currently has negative earnings. The Company’s CorPath system facilitates stent positioning for PCI procedures by allowing a physician to measure, manipulate, and advance devices with robotic precision; and CorPath GRX system enables the precise, robotic-assisted control of coronary guide catheters, guidewires, and balloon/stent devices from the safety of a radiation-shielded interventional cockpit.

More notable recent Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) news were published by: Marketwatch.com which released: “Warren Buffett’s stock picks crush Carl Icahn’s so far in 2016 – MarketWatch” on February 26, 2016, also Businesswire.com with their article: “Corindus to Showcase CorPath GRX® System for Peripheral Vascular Interventions at the 2018 Amputation Prevention Symposium – Business Wire” published on August 06, 2018, Businesswire.com published: “Corindus Names Aquilla S. Turk, D.O. as Chief Medical Officer, Neuroendovascular – Business Wire” on July 11, 2018. More interesting news about Corindus Vascular Robotics, Inc. (NYSEAMERICAN:CVRS) were released by: Businesswire.com and their article: “Corindus Announces First Live Transmission of Remote Robotic Demonstration Performed at Transcatheter Cardiovascular Therapeutics 2018 Conference – Business Wire” published on September 24, 2018 as well as Streetinsider.com‘s news article titled: “Corindus Vascular Robotics (CVRS) Announces FDA Clearance for First Automated Robotic Movement in technIQ Series for CorPath GRX Platform – StreetInsider.com” with publication date: March 05, 2018.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.